Dataset Information

Guidance on risk assessment of the application of nanoscience and nanotechnologies in the food and feed chain: Part 1, human and animal health.

ABSTRACT: The European Food Safety Authority has produced this Guidance on human and animal health aspects (Part 1) of the risk assessment of nanoscience and nanotechnology applications in the food and feed chain. It covers the application areas within EFSA's remit, e.g. novel foods, food contact materials, food/feed additives and pesticides. The Guidance takes account of the new developments that have taken place since publication of the previous Guidance in 2011. Potential future developments are suggested in the scientific literature for nanoencapsulated delivery systems and nanocomposites in applications such as novel foods, food/feed additives, biocides, pesticides and food contact materials. Therefore, the Guidance has taken account of relevant new scientific studies that provide more insights to physicochemical properties, exposure assessment and hazard characterisation of nanomaterials. It specifically elaborates on physicochemical characterisation of nanomaterials in terms of how to establish whether a material is a nanomaterial, the key parameters that should be measured, the methods and techniques that can be used for characterisation of nanomaterials and their determination in complex matrices. It also details the aspects relating to exposure assessment and hazard identification and characterisation. In particular, nanospecific considerations relating to in vivo/in vitro toxicological studies are discussed and a tiered framework for toxicological testing is outlined. It describes in vitro degradation, toxicokinetics, genotoxicity as well as general issues relating to testing of nanomaterials. Depending on the initial tier results, studies may be needed to investigate reproductive and developmental toxicity, immunotoxicity, allergenicity, neurotoxicity, effects on gut microbiome and endocrine activity. The possible use of read-across to fill data gaps as well as the potential use of integrated testing strategies and the knowledge of modes/mechanisms of action are also discussed. The Guidance proposes approaches to risk characterisation and uncertainty analysis, and provides recommendations for further research in this area.

SUBMITTER: EFSA Scientific Committee

PROVIDER: S-EPMC7009542 | biostudies-literature | 2018 Jul

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Guidance on risk assessment of the application of nanoscience and nanotechnologies in the food and feed chain: Part 1, human and animal health.

Hardy Anthony A Benford Diane D Halldorsson Thorhallur T Jeger Michael John MJ Knutsen Helle Katrine HK More Simon S Naegeli Hanspeter H Noteborn Hubert H Ockleford Colin C Ricci Antonia A Rychen Guido G Schlatter Josef R JR Silano Vittorio V Solecki Roland R Turck Dominique D Younes Maged M Chaudhry Qasim Q Cubadda Francesco F Gott David D Oomen Agnes A Weigel Stefan S Karamitrou Melpo M Schoonjans Reinhilde R Mortensen Alicja A

EFSA journal. European Food Safety Authority 20180704 7

The European Food Safety Authority has produced this Guidance on human and animal health aspects (Part 1) of the risk assessment of nanoscience and nanotechnology applications in the food and feed chain. It covers the application areas within EFSA's remit, e.g. novel foods, food contact materials, food/feed additives and pesticides. The Guidance takes account of the new developments that have taken place since publication of the previous Guidance in 2011. Potential future developments are sugges ...[more]

PMID: 32625968

Similar Datasets

Project description:Acetamide (CAS 60-35-5) is detected in common foods including milk, eggs, beef, and roasted coffee beans. Chronic rodent bioassays using high doses (≥1000 mg/kg/day) suggest acetamide is a group 2B possible human carcinogen due to the induction of liver tumors. Weight-of-evidence indicates acetamide is not genotoxic, and therefore a threshold response is expected. We used a toxicogenomics approach in Wistar rats gavaged daily for 7 and 28 days to determine the benchmark dose (BMD), and investigate its mode of action from differential gene expression. Two exposure experiements were carried out in succsession. An initial dose range finding experiment used male Wistar rats gavaged daily for 7 days at 0, 30, 100, 300 and 1000 mg/kd/day. A second experiment used both male and female Wistar rats exposed for 7 and 28 days to 0, 300,500,750,1000 and 1500 mg/kg/day. No treatment related changes in terminal body weight, clinical chemistry, or histopathology were observed at doses of 30, 100, or 300 mkd. At 1000 mkd, the dose reported to elicit carcinogenesis, liver weights decreased 1.3-fold with the presence of single cell necrosis, hepatocyte vacuolization, and increased mitotic activity consistent with a 4.2 fold increase in the cell proliferation index. Accordingly, plasma ALT and AST were increased 2.0- and 2.2-fold, respectively. RNA-Seq analysis identified 1 differentially expressed gene at 300 mkd, and 2,685 at 1000 mkd (|fold-change| ≥ 1.5 and FDR ≤ 0.05). Down-regulated genes were associated with lipid metabolism while up-regulated genes included cell signaling, immune response, and cell cycle functions. Collectively, these results revealed a no-observable adverse effect level (NOAEL) and no-observed-transcriptional effect level (NOTEL) at 300 mkd, warranting further investigation at doses between 300 and 1000 mkd to identify the benchmark dose (BMD). Functional enrichment indicates perturbation of cell cycle and lipid metabolism, though a more refined dose-response evaluation will be needed to demonstrate dose-dependent effects related to the MOA of acetamide. Funding by the Bill and Melinda Gates Foundation (OPP1142801).

Project description:Nickel (Ni) is a silvery-white, hard, ductile metal existing in oxidation states; in biological systems, Ni2+ is the prevalent form. All analytical results used to estimate animal dietary exposure were reported as Ni', without providing information on specific chemical species. Considering the data provided by Member states, among FoodEx level 1 feed categories, the highest mean Ni levels were measured in 'Minerals and products derived thereof' (n = 72). High mean Ni concentrations were also observed in 'Compound feed' (n = 516), in particular in complementary feeds for fattening cattles, unspecified complementary feed and complementary feeds for fattening pigs. Within grains used as feed (n = 597), the highest mean Ni concentrations were measured in oats. In addition, Ni concentrations in hydrogenated vegetable oils/fats were reported by industry. Exposure to Ni in livestock and companion animals varied according to the animal species. When considering the diets with hydrogenated vegetable oils/fats based on the reported Ni concentrations, the mean exposures varied between 6.0 μg Ni/kg body weight (bw) per day in cats and 79 μg Ni/kg bw per day in laying hens and the high exposure levels varied between 11 μg Ni/kg bw per day in cats and 127 μg Ni/kg bw per day in rabbits. The mean exposure estimates considering the maximum concentration of Ni assumed from good manufacturing practice in hydrogenated vegetable oils/fats (50 mg Ni/kg) varied between 27 μg Ni/kg bw per day in cats and 255 μg Ni/kg bw per day in rabbits; for the high concentration scenarios, exposures varied between 30 μg Ni/kg bw per day and 307 μg Ni/kg bw per day in the same species. The estimated exposures to Ni are in line with the one reported in the 2015 EFSA opinion, using a worst-case scenario. When estimating exposure with a realistic scenario, using the reported Ni concentration in hydrogenated vegetable oils/fats, the exposure of livestock and companion animals is lower (approximately from 1.5 to 6 times, depending on the species) than the 2015 assessment.

Dataset Information

Guidance on risk assessment of the application of nanoscience and nanotechnologies in the food and feed chain: Part 1, human and animal health.

Publications

Guidance on risk assessment of the application of nanoscience and nanotechnologies in the food and feed chain: Part 1, human and animal health.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets